Jean-Marc Ferran

Statistics

Publications

Citations

282

H-Index

Active since

2007

Affiliations

Novo Nordisk (Denmark)(Current)

Novo Nordisk (United States)

University of Cincinnati

Columbia University

Jean-Marc Ferran is an author at Novo Nordisk (Denmark) specializing in health-related quality of life measurement, stroke, and recombinant activated factor vii.

ORCID

Publications per year

2007–2023

Publications

Quality of Life After Intracerebral Hemorrhage

Michael Cronquist Christensen, Stephan A. Mayer, Jean-Marc Ferran · Stroke · 2009 · 101 citations

Pharmacy, Neurology, Cost-utility Analysis +12

Secondary prophylaxis with recombinant activated factor VII improves health‐related quality of life of haemophilia patients with inhibitors

W. Keith Hoots, Liselotte S. Ebbesen, Barbara A. Konkle et al. · Haemophilia · 2008 · 95 citations · Full text

Medicine, Hematology, Pharmacotherapy +9

Depressed Mood after Intracerebral Hemorrhage: The FAST Trial

Michael Cronquist Christensen, Stephan A. Mayer, Jean-Marc Ferran et al. · Cerebrovascular Diseases · 2009 · 64 citations

Nursing, Neurology, Psychiatry +17

Impact of Recombinant Activated Factor VII on Health-Related Quality of Life after Intracerebral Hemorrhage

Michael N. Diringer, Jean-Marc Ferran, Joseph Broderick et al. · Cerebrovascular Diseases · 2007 · 11 citations

Pharmacy, Pharmacology, Pharmacotherapy +11

Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER

Beverly M. K. Biller, Charlotte Höybye, Jean-Marc Ferran et al. · Journal of the Endocrine Society · 2023 · 11 citations · Full text

Medicine, Geriatric Medicine, Internal Medicine +12

1–5 of 5